Merck (@Merck) “In collaboration with @moderna_tx, we’re excited to share the first positive Pha” — TopicDigg
Merck
@Merck
加入 April 2009
0 正在关注 0 粉丝
In collaboration with @moderna_tx, we’re excited to share the first positive Phase 3 topline results for our investigational individualized neoantigen therapy (INT) in combination with our company’s immunotherapy in the adjuvant setting for certain patients with completely resected stage IIB-IV #melanoma#:
显示更多
